Therapeutic protein selection in simulated in vivo conditions | Patent Number 11879896

US 11879896 B2
Application Number17892618
Publication NumberUS 20230066527 A1
Pendency1 year, 5 months, 4 days
Filled DateAug 22, 2022
Priority DateAug 13, 2018
Publication DateMar 2, 2023
Expiration DateAug 12, 2038
Inventor/ApplicantsDorothy Kim
Michael Marlow
ExaminesYAKOVLEVA, GALINA M
Art Unit1678
Technology Center1600
Assignments
Regeneron Pharmaceuticals
Current
Regeneron Pharmaceuticals
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.